Oct 07, 2021 / 12:30PM GMT
Operator
Welcome, everyone, to the Brickell Biotech conference call announcing topline data from the U.S. Phase III pivotal program for sofpironium bromide gel, 15%. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the call over to Garth Russell from LifeSci Advisors.
Garth Russell -
Thank you, and good morning, everyone. I would like to first mention that there is a presentation accompanying management's prepared remarks on today's call which is available on the Events and Presentations page of the Investor Relations section of the company's website, www.brickellbio.com. Joining me on today's call are Brickell's Chief Executive Officer, Rob Brown; Chief R&D Officer, Deepak Chadha; Chief Medical Officer, Dr. Monica Luchi; Chief Operating Officer, Andy Sklawer; and Chief Financial Officer, Bert Marchio.
Turning to Slide 2. This presentation contains forward-looking statements. Please reference this slide and our recent SEC filings for additional
Brickell Biotech Inc Topline Results from Phase 3 Pivotal Cardigan Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers